11:29 AM
 | 
Jun 29, 2017
 |  BC Extra  |  Financial News

Indi Molecular raises $11.5M in series A round

Indi Molecular Inc. (Culver City, Calif.) said it raised $11.5 million in a series A round led by M Ventures, the venture arm of Merck KGaA (Xetra:MRK). Also participating were Legend Capital, Sabey Corp. (Seattle, Wash.), and Asset Management Ventures.

Indi uses its protein-catalyzed capture (PCC) platform to produce synthetic peptides that could...

Read the full 251 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >